fda compounding semaglutide crackdown november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA is short-sighted on compounding
Description
doi: 10.3390/medicines9090047

The only FDA-approved oral form is Rybelsus, manufactured by Novo Nordisk for Type 2 diabetes

re-esterification of free fatty acids to triglyceride) [9]

10.1016/S0140-6736(87)91194-9 78

List of Sources Explore GLP-1 Medications: Mechanisms and Benefits news.sanfordhealth.org ( uchicagomedicine.org ( newsroom.uvahealth.com ( source.washu.edu ( Head-to-head Study Shows Bariatric Surgery Superior to GLP-1 Drugs for Weight Loss ( Identify Causes of Fatigue on GLP-1: Understanding the Science Semaglutide Fatigue: Does Semaglutide Make You Tired